产品标题 产品货号 产品规格 厂家
CXXC finger 1 (PHD domain) (CXXC1), transcript variant 2 from ORIGENE TECHNOLOGIESLY402351100 ugORIGENE TECHNOLOGIES
CXXC5 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4029631 kitORIGENE TECHNOLOGIES
CXXC1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4039371 kitORIGENE TECHNOLOGIES
CXXC4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4128341 kitORIGENE TECHNOLOGIES
Cxx1c - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5040571 kitORIGENE TECHNOLOGIES
Cxxc1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5040581 kitORIGENE TECHNOLOGIES
Cxxc4 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5040591 kitORIGENE TECHNOLOGIES
Cxxc5 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5040601 kitORIGENE TECHNOLOGIES
Cxxc5 - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN3040601 kitORIGENE TECHNOLOGIES
Cxxc5 - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN304060BN1 kitORIGENE TECHNOLOGIES
Cxxc5 - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN304060LP1 kitORIGENE TECHNOLOGIES
Cxxc5 - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN304060RB1 kitORIGENE TECHNOLOGIES
Human Breast, left; Adenocarcinoma of breast, ductal (HER2+) from ORIGENE TECHNOLOGIESCS7099595x5umORIGENE TECHNOLOGIES
Human Breast, left; Adenocarcinoma of breast, ductal, mucinous from ORIGENE TECHNOLOGIESCS7115835x5umORIGENE TECHNOLOGIES
Human Breast, left; Adenocarcinoma of breast, ductal, mucinous from ORIGENE TECHNOLOGIESCS7115885x5umORIGENE TECHNOLOGIES
Human Breast, left; Adenocarcinoma of breast, ductal, mucinous from ORIGENE TECHNOLOGIESCS8144745x5umORIGENE TECHNOLOGIES
Human Breast, left; Adenocarcinoma of breast, ductal (triple negative) from ORIGENE TECHNOLOGIESCS5492825x5umORIGENE TECHNOLOGIES
Human Breast, left; Apocrine metaplasia of breast from ORIGENE TECHNOLOGIESCS7151375x5umORIGENE TECHNOLOGIES
Human Breast, left; Biopsy site changes from ORIGENE TECHNOLOGIESCS5320135x5umORIGENE TECHNOLOGIES
Human Breast, left; Biopsy site changes from ORIGENE TECHNOLOGIESCS5526655x5umORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast from ORIGENE TECHNOLOGIESCS7151715x5umORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast from ORIGENE TECHNOLOGIESCS5508945x5umORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast from ORIGENE TECHNOLOGIESCS6122745x5umORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast, ductal from ORIGENE TECHNOLOGIESCS7145575x5umORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast, ductal from ORIGENE TECHNOLOGIESCS8140215x5umORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast, ductal from ORIGENE TECHNOLOGIESCS5488845x5umORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast, ductal from ORIGENE TECHNOLOGIESCS5489015x5umORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast, ductal from ORIGENE TECHNOLOGIESCS5526675x5umORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast, ductal from ORIGENE TECHNOLOGIESCS6505825x5umORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast, ductal, papillary from ORIGENE TECHNOLOGIESCS8140235x5umORIGENE TECHNOLOGIES
Human Breast, left; Ductal ectasia of breast from ORIGENE TECHNOLOGIESCS5440495x5umORIGENE TECHNOLOGIES
Human Breast, left; Ductal ectasia of breast from ORIGENE TECHNOLOGIESCS5440505x5umORIGENE TECHNOLOGIES
Human Breast, left; Ductal ectasia of breast from ORIGENE TECHNOLOGIESCS5440515x5umORIGENE TECHNOLOGIES
Human Breast, left; Ductal ectasia of breast from ORIGENE TECHNOLOGIESCS5440525x5umORIGENE TECHNOLOGIES
Human Breast, left; Ductal hyperplasia of breast, atypical from ORIGENE TECHNOLOGIESCS8147165x5umORIGENE TECHNOLOGIES
Human Breast, left; Fibroadenoma of breast from ORIGENE TECHNOLOGIESCS5525115x5umORIGENE TECHNOLOGIES
Human Breast, left; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7134565x5umORIGENE TECHNOLOGIES
Dcdc2b - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5043191 kitORIGENE TECHNOLOGIES
Dcdc2c - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5043201 kitORIGENE TECHNOLOGIES
DCDC2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4087211 kitORIGENE TECHNOLOGIES
DCDC1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4217491 kitORIGENE TECHNOLOGIES
DCDC2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30872110 ugORIGENE TECHNOLOGIES
DCD - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4093521 kitORIGENE TECHNOLOGIES
DCD Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30935210 ugORIGENE TECHNOLOGIES
DCHS2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4188741 kitORIGENE TECHNOLOGIES
DCHS1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4197351 kitORIGENE TECHNOLOGIES
Dchs1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5043211 kitORIGENE TECHNOLOGIES
DCK - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4107671 kitORIGENE TECHNOLOGIES
Dck - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5043221 kitORIGENE TECHNOLOGIES
DCK Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH31076710 ugORIGENE TECHNOLOGIES
 |< < 2035 2036 2037 2038 2039 2040 2041 2042 2043 > >| 第 2036/6274 页